Teuvo L. Tammela
Tampere, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 419 publications
Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
Journal: BJU international
Published: July 04, 2026
Correction: Renal cancer survival in clear cell renal cancer compared to other types of tumor histology: A population-based cohort study.
Journal: PloS one
Published: January 29, 2026
European Study of Prostate Cancer Screening - 23-Year Follow-up.
Journal: The New England journal of medicine
Published: October 29, 2025
Is Exercise During Androgen Deprivation Therapy Effective and Safe? A Randomized Controlled Trial.
Journal: Scandinavian journal of medicine & science in sports
Published: February 14, 2025
Risk factors for low-risk prostate cancer: A retrospective cohort study within the FinRSPC trial.
Journal: International journal of cancer
Published: December 18, 2024
SNP genotypes in CYP2C9 and VKORC1 genes do not affect prostate cancer or cancer mortality among warfarin users in Finnish prostate cancer patients.
Journal: PloS one
Published: November 14, 2024
Quadratus lumborum block is feasible alternative to epidural block for postoperative analgesia after open radical cystectomy: surgical and oncological outcomes of a randomised clinical trial.
Journal: Scandinavian journal of urology
Published: October 24, 2024
Do differences in secondary treatment explain mortality impact of prostate cancer screening? - A randomized screening trial.
Journal: Urologic oncology
Published: October 13, 2024
Elevated Levels of Serum Thymidine Kinase 1 Predict Poor Survival for Patients with Metastatic Prostate Cancer.
Journal: European urology open science
Published: October 09, 2024
Effect of NSAID Consumption on Renal Cell Carcinoma Prognosis: A Population-Based Study.
Journal: Clinical genitourinary cancer
Published: August 27, 2024
Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml: Evidence from the Finnish Randomized Study of Screening for Prostate Cancer.
Journal: European urology oncology
Published: August 17, 2024
Last Updated: 09/26/2026